🌐 WorldLive
Accueil › 🇺🇸 États-Unis › Santé

Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in ...

Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in ...

– Primary endpoint of endoscopic nasal polyp score (NPS) showed reduction of -1.95 (p < 0.0001)in new analysiswith adjustment for concomitant rescue therapy use –